A Phase 2 Dose Ranging, Randomized, Double Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects with Primary Biliary Cholangitis (PBC) with or without an Inadequate Response to Ursodeoxycholic Acid (UDCA)

  • Hodge, Alex (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date16/11/1815/11/23